We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

HORMONAL CONTRACEPTIVES MARKET ANALYSIS

Hormonal Contraceptives Market, by Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Ring, and Transdermal Patches), by Hormone (Progestin Only Contraceptive and Combined Hormonal Contraceptive), by Age Group (15–24 Years, 25–34 Years, 35–44 Years, and Above 44 Years), by End User (Hospitals, Homecare, Gynecology Centers, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Published In : Sep 2021
  • Code : CMI4615
  • Pages :195
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Hormonal contraceptives contain a progestin (progesterone medicine) with or without an estrogen. Both progestin and estrogen are manufactured in a laboratory and are similar to the hormones naturally produced by all women. These two hormones are used together, or the progestin alone, to prevent pregnancy in various ways such as preventing ovulation (release of eggs), thickening the mucus around the cervix (mouth of the uterus), preventing sperm from entering the uterus (uterus), or they thin the inner wall of the uterus (uterus) to prevent the attachment of fertilized eggs.

The global hormonal contraceptives market is estimated to be US$ 15,232.2 Million in 2021 and is expected to reach US$ 18,577.6 million by 2028, at a CAGR of 2.9% during the forecast period (2021 –2028).

Figure 1. Global Hormonal Contraceptives Market Value (US$ Mn) & Y-o-Y Growth (%)

HORMONAL CONTRACEPTIVES MARKET

To learn more about this report, request sample copy

The increasing number of unintended pregnancies is expected to drive the market growth over the forecast period.

Increasing number of unintended pregnancies is expected to boost the growth of global hormonal contraceptives market during the forecast period. As per a publication in PubMed, the number of unintended pregnancies in the U.S are around three million annually. Hence, a Maternal and Infant Health Initiative was established by the Center for Medicaid and CHIP Services (CMCS) for the Medicaid and Children’s Health Insurance Program (CHIP) to promote use of effective methods of contraception and help women avoid such pregnancies.

Hormonal Contraceptives Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 15,232.2 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 2.9% 2028 Value Projection: US$ 18,577.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product: Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Ring, Transdermal Patches
  • By Hormone: Progestin Only Contraceptive, Combined Hormonal Contraceptive
  • By Age Group: 15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years
  • By End User: Hospitals, Homecare, Gynecology Centers, Clinics, Ambulatory Surgical Centers
Companies covered:

The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.

Growth Drivers:
  • Increasing population
  • Increasing focus on family planning
  • Initiatives taken by the respective government to raise awareness about the use of contraceptives
Restraints & Challenges:
  • Side effects associated with hormonal contraceptives
  • Lack of social acceptance

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Figure 2. Global Hormonal Contraceptives Market Share (%), by Hormone, 2021

HORMONAL CONTRACEPTIVES MARKET

To learn more about this report, request sample copy

Global Hormonal Contraceptives Market – Regional Analysis:

North America is anticipated to dominate the global market during the forecast period due to the presence of major market players, high number of unintended pregnancies, high per capita income, and increasing government initiatives. The developed countries in Europe such as the U.K. and Germany have deep-rooted healthcare infrastructure and high awareness concerning hormonal contraception which is expected to boost regional growth. Asia Pacific is estimated to witness rapid growth in the upcoming years due to increasing number of women in their reproductive age and due to high unmet needs.

Global Hormonal Contraceptives Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency in 2020. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported in the U.S. as of July 28, 2021 are approximately 195,266,156 with around 4,180,161 deaths. The Coronavirus or COVID-19 outbreak started from Wuhan, China and has spread across continents, affecting various industries globally. Globally, reproductive health services such as contraception and abortion services are either shut down or not accessible. According to report published by the International Planned Parenthood Federation, the anticipated shortages of contraception as lockdown and measures put in to curtail the pandemic lead to a reduction in the manufacturing of contraceptives. The United Nations Population Fund (UNFPA) technical note estimated that due to measures taken for COVID-19 containment, about 47 million women in 114 low- and middle-income countries, including India, will not be able to use contraception and this would result in seven million unintended pregnancies.

Global Hormonal Contraceptives Market: Restraint

The side effects associated as well as lack of social acceptance of hormonal contraceptives is the major factors that is expected to hinder the growth of the global hormonal contraceptives market. Side effects include headache, nausea, sore breasts, vaginal yeast infections, and risk of blood clots formation which is higher in women over the age of 40 and in women who smoke, are overweight or have a higher risk of vascular disease in their family.

Key Players

Major players operating in the global hormonal contraceptives market include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.

Share

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The global Hormonal Contraceptives Market size was valued at USD 15,232.2 million in 2021 and is expected to reach USD 18,577.6 million in 2028.

The global hormonal contraceptives market size is estimated to be valued at US$ 15,232.2 Million in 2021 and is expected to exhibit a CAGR of 2.9% between 2021 and 2028.

Initiatives taken by the respective government to raise awareness about the use of contraceptives, rise in menstruating population worldwide, and increasing focus on family planning are fuelling the growth of the market.

The oral contraceptive pills segment is the leading product type segment in the market.

Side effects associated with hormonal contraceptives is the major factor restraining growth of the market.

Major players operating in the market include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Select a License Type





Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.